Drug costs developments after patent expiry of enalapril, fluoxetine and ranitidine: A study conducted for the Netherlands

Cornelis Boersma, Rogier M. Klok, Jasper M. Bos, Mark Naunton, Paul B. Van Den Berg, Lolkje T.W. De Jongvan Den Berg, Maarten J. Postma

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Drug costs developments after patent expiry of enalapril, fluoxetine and ranitidine: A study conducted for the Netherlands'. Together they form a unique fingerprint.

Medicine & Life Sciences

Business & Economics